SOTATERCEPT Drug Record

  • SOTATERCEPT chembl:CHEMBL1743073

    Alternate Names:

    SOTATERCEPT
    ACE-011
    ACE-001

    Drug Info:

    FDA Approval not approved
    Drug Class fusion protein
    Drug Indications erythropoietic agent,antiosteoporotic agent
    (0 More Sources)

    Publications:

  • SOTATERCEPT   INHBA

    Interaction Score: 20.61

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Inhibin beta A chain inhibitor
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • SOTATERCEPT   ACVR2A

    Interaction Score: 10.3

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ACE-011
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • SOTATERCEPT   TGFB1

    Interaction Score: 0.56

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • TdgClinicalTrial: ACE-011

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications erythropoietic agent,antiosteoporotic agent
    Drug Class fusion protein
    FDA Approval not approved

    Publications:

  • TTD: ACE-011

    • Version: 2020.06.01

    Alternate Names:
    D0F7GX TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1743073

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL1743073

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: